Ripple announced that Brazilian asset manager VERT has completed its second on-chain issuance, bringing over $40 million in regulated credit backed by public-pension receivables to the XRP Ledger. This marks another major step for Brazil’s financial modernization, as the nation continues to merge compliance-ready blockchain infrastructure with traditional finance. Earlier this year, VERT launched its […]Ripple announced that Brazilian asset manager VERT has completed its second on-chain issuance, bringing over $40 million in regulated credit backed by public-pension receivables to the XRP Ledger. This marks another major step for Brazil’s financial modernization, as the nation continues to merge compliance-ready blockchain infrastructure with traditional finance. Earlier this year, VERT launched its […]

Ripple’s XRP Ledger Ignites Brazil’s Digital Finance Boom with VERT’s $40M Tokenized Fund

XRP Ledger
  • Ripple and VERT have completed a $40 million regulated credit issuance on the XRP Ledger.
  • Brazil leads the global shift to compliant, blockchain-powered finance.
  • VERT’s second on-chain fund marks a new phase in tokenized credit adoption.

Ripple announced that Brazilian asset manager VERT has completed its second on-chain issuance, bringing over $40 million in regulated credit backed by public-pension receivables to the XRP Ledger. This marks another major step for Brazil’s financial modernization, as the nation continues to merge compliance-ready blockchain infrastructure with traditional finance.

Earlier this year, VERT launched its first tokenized fund on the XRP Ledger and its EVM Sidechain. Just three months later, the company has expanded its operations with a second issuance, showing that tokenization in Brazil is moving from early trials to mainstream market use. The latest fund is backed by public-pension receivables, considered one of the country’s most stable and low-risk financial assets.

Each receivable represents a share of monthly pension payments owed by Brazil’s federal government, giving investors access to predictable, government-backed cash flows. The current fund manages around BRL 200 million (USD 40 million) in assets and aims to grow to BRL 1 billion (USD 190 million) as institutional interest accelerates.

Automation and Compliance on the XRP Ledger

VERT’s latest move introduces VERT Sign, a document-signing and verification solution built on the XRPL EVM Sidechain. This system automates the purchase and management of receivables through verifiable digital signatures and wallet-based execution, cutting down manual work and operational risks.

According to a remark by Gabriel Braga, Digital Assets Director at VERT, the automation and compliance system enables the tokenized financial assets to shift from being mere digital replicas to fully-fledged assets.

This system is responsible for storing all documents and payments directly on the blockchain system, making it possible to audit the entire system with a one-way efficiency that meets the Brazilian market’s compliance requirements for the issuance of securities.

Both VERT and fintech company BYX intend to further advance their concept of tokenization by the end of the current year by relating credit issuance to the management of portfolios using blockchain technology.

Setting a Global Example for Regulated Blockchain Finance

Ripple and VERT are also partnering with the Securities and Exchange Commission of Brazil with the LEAP program, which is a research project that aims to investigate the application of blockchain technology for secondary trading in a regulated market environment. This project aims to enhance secondary trading of the funding of securities using the DEX of the XRP Ledger.

Silvio Pegado, the Managing Director for LATAM at Ripple, pointed out that Brazil’s strategy demonstrates that regulation and innovation can progress together. VERT has closed over 390 structured credit agreements in the last nine years, with a value of issuances of BRL 104 billion. VERT’s collaboration with Ripple places Brazil at the forefront of the integration of compliance, transparency, and digital finance.

Also Read: Ripple’s RLUSD Stablecoin Hits $789M, Driving XRP Ledger’s Institutional Boom

Market Opportunity
XRP Logo
XRP Price(XRP)
$1,9102
$1,9102$1,9102
-0,21%
USD
XRP (XRP) Live Price Chart
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact service@support.mexc.com for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

Trump Filed a Lawsuit Against JPMorgan Chase And Its CEO Over Debanking

Trump Filed a Lawsuit Against JPMorgan Chase And Its CEO Over Debanking

U.S. President Donald Trump filed a lawsuit against JPMorgan Chase and its CEO Jamie Dimon personally, accusing the institution of deliberate debanking. The politician
Share
Incrypted2026/01/23 15:59
Here’s why Polygon price is at risk of a 25% plunge

Here’s why Polygon price is at risk of a 25% plunge

Polygon price continued its freefall, reaching its lowest level since April 21, as the broader crypto sell-off gained momentum. Polygon (POL) dropped to $0.1915, down 32% from its highest point in May and 74% below its 2024 peak. The crash…
Share
Crypto.news2025/06/19 00:56
Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

The post Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution appeared on BitcoinEthereumNews.com. In this week’s edition of InnovationRx, we look at possible pain treatments from cannabis, risks of new vaccine restrictions, virtual clinical trials at the Mayo Clinic, GSK’s $30 billion U.S. manufacturing commitment, and more. To get it in your inbox, subscribe here. Despite their addictive nature, opioids continue to be a major treatment for pain due to a lack of effective alternatives. In an effort to boost new drugs, the FDA released new guidelines for non-opioid painkillers last week. But making these drugs hasn’t been easy. Vertex Pharmaceuticals received FDA approval for its non-opioid Journavx in January, then abandoned a next generation drug after a failed clinical trial earlier this summer. Acadia similarly abandoned a promising candidate after a failed trial in 2022. One possible basis for non-opioids might be cannabis. Earlier this year, researchers at Washington University at St. Louis and Stanford published a study showing that a cannabis-derived compound successfully eased pain in mice with minimal side effects. Munich-based pharmaceutical company Vertanical is perhaps the furthest along in this quest. It is developing a cannabinoid-based extract to treat chronic pain it hopes will soon become an approved medicine, first in the European Union and eventually in the United States. The drug, currently called Ver-01, packs enough low levels of cannabinoids (including THC) to relieve pain, but not so much that patients get high. Founder Clemens Fischer, a 50-year-old medical doctor and serial pharmaceutical and supplement entrepreneur, hopes it will become the first cannabis-based painkiller prescribed by physicians and covered by insurance. Fischer founded Vertanical, with his business partner Madlena Hohlefelder, in 2017, and has invested more than $250 million of his own money in it. With a cannabis cultivation site and drug manufacturing plant in Denmark, Vertanical has successfully passed phase III clinical trials in Germany and expects…
Share
BitcoinEthereumNews2025/09/18 05:26